- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: IVAC
Total 192 results
-
Assistance Publique - Hôpitaux de ParisVaincre la MucoviscidoseCompletedCystic FibrosisFrance
-
Children's Hospital of PhiladelphiaVertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada
-
Vertex Pharmaceuticals IncorporatedCompletedCystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR MutationUnited States, France, United Kingdom, Germany, Spain, Belgium, Canada, Australia, Netherlands, Denmark, Czech Republic, Italy, Austria, Ireland, Sweden
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States, France, Belgium, United Kingdom
-
University of Alabama at BirminghamCompleted
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States, United Kingdom, Canada
-
Nivalis Therapeutics, Inc.Unknown
-
University of Missouri-ColumbiaMedtronicCompletedFractures, ClosedUnited States
-
Swedish Medical CenterMallinckrodtUnknown
-
Vertex Pharmaceuticals IncorporatedCompletedCystic Fibrosis, Homozygous for the F508del CFTR MutationUnited States, France, Spain, Belgium, Canada, Austria, Australia, Germany, United Kingdom, Denmark
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States
-
The AlfredUnknown
-
Concert PharmaceuticalsCompleted
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States, United Kingdom, Canada
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, France, United Kingdom, Germany, Australia, New Zealand, Belgium
-
Concert PharmaceuticalsCompleted
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationTerminated
-
Vertex Pharmaceuticals IncorporatedCompletedCystic Fibrosis, Homozygous for the F508del CFTR MutationUnited States, Germany, Canada, Netherlands, Czech Republic, Italy, Ireland, Sweden, United Kingdom, Australia, France
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States, France, United Kingdom, Germany, Canada, Czech Republic, Ireland, Australia
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States, France, Belgium
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompleted
-
Medical University of WarsawUnknown
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedHealthy | Hepatic ImpairmentSlovakia, Czech Republic
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Cancer Research UKUnknown
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited Kingdom, United States, Canada
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States, Canada, Australia, Ireland, France, United Kingdom, Germany, Czech Republic
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States, Canada, Germany
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedStudy of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation (ENVISION)Cystic FibrosisUnited States, Australia, Canada, France, Germany, Ireland, United Kingdom
-
Vertex Pharmaceuticals IncorporatedApproved for marketingCystic Fibrosis
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedIn Development for Cystic FibrosisCzech Republic, Slovakia
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Cooperative Study Group A for HematologyUnknownAcute Lymphoblastic LeukemiaKorea, Republic of